Dr. Reddy’s develops direct-to-consumer e-commerce website ‘Celevida Wellness’ for diabetes

Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, today announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by its wholly-owned subsidiary, Svaas Wellness Limited. ‘Celevida Wellness’ aims to become a one-stop solution for personalised diabetic care for Type 2 diabetic and pre-diabetic individuals.

The CelevidaWellness website will offer a comprehensive range of products for diabetic patients, catering to their daily nutritional needs and fitting into the day’s meal schedule. The platform is based on rigorous product selection and nutritional composition studies.

Launched in 2019, Celevida has been the leading nutrition brand for diabetes management, and its launch enables the Celevida range and other brands to reach consumers directly. The website currently delivers to over 18,000 pin codes across India. M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), said: “With ‘Celevida Wellness’, our aim will be to learn constantly and work towards offering best-in-class consumer experience. We will also be able to create capabilities that can be scaled and replicated across markets.”